Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.
作者信息
Kalac Matko, Lue Jennifer K, Lichtenstein Emily, Turenne Ithamar, Rojas Celeste, Amengual Jennifer E, Sawas Ahmed, Deng Changchun, Mapara Markus Y, Connors Joseph M, Kuruvilla John, O'Connor Owen A
机构信息
Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA.
Department of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA.
出版信息
Br J Haematol. 2018 Mar;180(5):757-760. doi: 10.1111/bjh.14449. Epub 2016 Dec 16.
PMID:27984643
Abstract
摘要
Zotero 插件